Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset

OBJECTIVE: Intravenous tissue plasminogen activator (tPA) is the standard therapy for patients with acute ischaemic stroke (AIS) within 4.5 hours of onset. Recent trials have expanded the endovascular treatment window to 24 hours. We investigated the efficacy and safety of using multimodal MRI to gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jie, Zhao, Hongmei, Li, Runtao, Li, Jiangtao, Liu, Chang, Lv, Juan, Li, Yanan, Liu, Wei, Ma, Dongpu, Hao, Huaihai, Xiao, Xinguang, Liu, Junzhong, Yin, Yongfeng, Liu, Rongli, Yu, Qiaoyan, Wei, Yingjie, Li, Pengyan, Wang, Yue, Wang, Runqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475086/
https://www.ncbi.nlm.nih.gov/pubmed/31105972
http://dx.doi.org/10.1136/svn-2018-000151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475086/
https://www.ncbi.nlm.nih.gov/pubmed/31105972
http://dx.doi.org/10.1136/svn-2018-000151

Ejemplares similares